Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Registration NOW open for the Best of ASRM and ESHRE 2025 !

ESHRE Position statements and papers

Statements, opinions, responses about recent highlights and milestones in the field of reproductive science and medicine can be found in this section .

Treatment add-ons

19 October 2023 - The responsible use of treatment add-ons in fertility services: a consensus statement

Read here >

Polygenic risk scores

February 2022 - ESHRE supports the position of ESHG on embryo selection based on polygenic risk scores

Read here >

COVID-19 and assisted reproduction

Read more ESHRE statements on COVID-19 >

Discrimination and bigotry

8 June 2020 - ESHRE reaffirms its opposition to discrimination and bigotry

Read here >

Spindle transfer

9 July 2019 - Spindle transfer in the treatment of infertility: an ESHRE position statement

Read here >

Gene editing in human embryos

22 March 2019 - Moratorium on Gene Editing in human embryos

Read here >

Safety and Access to Fertility Care

13 December 2018 - ESHRE supports WHO Global Summit on Safety and Access to Fertility Care

Read here >

Stem cells in reproductive medicine

22 July 2015 - Stem cells in reproductive medicine: ready for the patient?

Read here >

Birth defects

7 April 2009 - Birth defects in IVF children

Download pdf >

Reproductive cloning of human beings

1 August 2007 - Prolongation of Voluntary Moratorium on Reproductive Cloning of Human Beings

Download pdf >

Good Clinical Treatment

June 2008 - Good Clinical Treatment in Assisted Reproduction

Download pdf >

Prion detection in urinary gonadotropin formulations

ESHRE position statement concerning prion detection in urinary gonadotropin formulations

Download pdf >

Ethics statements

Ethics and Law Taskforce Documents

Read here >
These position statements are directed at professionals. For position statements directed at policy makers, please go to this page